Results 21 to 30 of about 3,788,205 (194)
Epithelial Ovarian Cancers and Endometriosis [PDF]
Gynecologic and Obstetric Investigation, 2015 <b><i>Aims:</i></b> To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma. <b><i>Methods:</i></b> An observational cohort study performed in 192 patients operated on for EOC, 30 women with ...Acién, Pedro, Velasco-Ruiz, Irene, Acién, Maribel, Capello, Cecilia, Vela, Pilar +4 moreopenaire +3 more sourcesThe cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer [PDF]
, 2012 Carboplatin remains a first-line agent in the management of epithelial ovarian cancer (EOC). Unfortunately, platinum-resistant disease ultimately occurs in most patients.Madhuri, K, Giannopoulos, T, P Chivers, D P Lovell, Crook, T, H M Coley, E Papacharalbous, T Giannopoulos, Coley, HM, Butler-Manuel, S, S Butler-Manuel, K Madhuri, Papacharalbous, E, Lovell, DP, N A M Safuwan, Safuwan, NA, T Crook, Chivers, P +17 morecore +1 more sourceFunctional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers [PDF]
, 2011 Genetic variation at the TERT-CLPTM1L locus at 5p15.33 is associated with susceptibility to several cancers, including
epithelial ovarian cancer (EOC). We have carried out fine-mapping of this region in EOC which implicates an association with
a single Chaiwerawattana, A, Palmieri, RT, Beesley, Jonathan, Orlow, Irene, Pickett, Hilda A., Lophatananon, A, Kelemen Linda E., Rayna K Matsuno, Kiemeney, L.A.L.M., Ingo B Runnebaum, Lurie, G., Dörk Thilo, Aben, KKH, Despierre Evelyn, Wang-Gohrke, Shan, Le, ND, Kenneth Muir, Fridley Brooke L., Lurie, Galina, Wilkens, LR, Simon A. Gayther, Natalia Antonenkova, Chaiwerawattana, A., Kiemeney Lambertus A., Wilkens Lynne R., Marees Tamara, Chaiwerawattana, Arkom, Tamara Marees, Muir, K, Vierkant, R.A., Orlow Irene, Aben Katja K. H., Marc T Goodman, Campbell, I., Rodriguez-Rodriguez Lorna, Nickels, Stefan, Menon Usha, Dunning, A.M., Wiangnon, S., Usha Menon, Sandrina Lambrechts, null null, Angela Brooks-Wilson, Wiangnon, S, Robert A Vierkant, Jenny Chang-Claude, Vrieling Alina, HASH(0x55a67f4ed3f8), Ian Campbell, Lambrechts Diether, Olson Sara H., Paul D Pharoah, Georgia Chenevix-Trench, Campbell, I, Cook, LS, Lambrechts, D., Wiangnon Surapon, Alina Vrieling, Stutz, M.D., Macgregor, Stuart, Antonenkova Natalia, Olson, S.H., Lynne R. Wilkens, Despierre, E., Caroline Baynes, Michailidou, K., Wang-Gohrke, S., Aben, K.K.H., Despierre, E, Easton Douglas F., Vrieling, A, Menon, U., Ahmed, S, Ignace Vergote, Wiangnon, Surapon, Runnebaum, I.B., Linda S. Cook, Dunning, AM, Palmieri Rachel T., Goodman, MT, Roger R. Reddel, Massuger, Leon F. A. G., Easton, DF, Massuger, L.F.A.G., Bandera, EV, Ellen L Goode, Douglas F. Easton, Antonenkova, N., Vierkant Robert A., Australian Ovarian Can Study Grp, Massuger Leon F. A. G., Bandera Elisa V., Sara H. Olson, Ahmed, S., Pickett Hilda A., Dunning Alison M., Goodman Marc T., Rodriguez-Rodriguez, Lorna, Sharon E. Johnatty, Stutz, MD, Fridley, BL, Rodriguez-Rodriguez, L, Ramus Susan J., Le, Nhu D., Runnebaum Ingo B., Brooks-Wilson Angela, Jun Li, Simon A Gayther, Nickels, S., Pharoah, P.D., Muir, Kenneth (Kenneth R.), Michailidou, Kyriaki, Cook, Linda S., Chenevix-Trench, Georgia, Brooks-Wilson, A, Ellen L. Goode, Runnebaum, IB, Ramus, S.J., Bogdanova, N, Lu, Y., Arkom Chaiwerawattana, Rider, D.N., Chang-Claude, J, Gentry-Maharaj, Aleksandra, Natalia Bogdanova, Wilkens, Lynne R., Irene Orlow, Wilkens, L.R., Leon F. A. G. Massuger, Kyriaki Michailidou, Palmieri, Rachel T., Menon, U, Investigators kConFab, Gayther, Simon A., Thilo Dörk, David N Rider, Lambertus A. Kiemeney, Kiemeney, Lambertus A., Olson, Sara H., Flesch-Janys Dieter, Li, J, ABCTB Investigators, Wang-Gohrke, S, Le Nhu D., HASH(0x55a67f3e5a40), Johnatty, S.E., Vrieling, Alina, Dork, T., Stutz Michael D., Flesch-Janys, Dieter, Baynes, C., Marees, Tamara, Michael D. Stutz, Marees, T, David N. Rider, Ingo B. Runnebaum, Lophatananon, A., Baynes, Caroline, Lambrechts, S, Orlow, I, Li Jun, Matsuno Rayna K., Baynes, C, Li, Jun, Goode, Ellen L., Reddel Roger R., Katja K H Aben, Kelemen, L.E., Goode, E.L., Lambrechts, D, Antonenkova, Natalia, Matsuno, RK, Vergote, I, Lu, Yi, Le, N.D., Lurie Galina, Rayna K. Matsuno, Lophatananon, Artitaya, Lurie, G, Susan J. Ramus, Paul D. Pharoah, Brooke L. Fridley, Leon F A G Massuger, Vergote, Ignace, Artitaya Lophatananon, Brooks-Wilson, Angela, Jonathan Beesley, Beesley, J., Baynes Caroline, Rachel T Palmieri, Fridley, B.L., Elisa V Bandera, Eilber, Ursula, Antonenkova, N, Rodriguez-Rodriguez, L., Bogdanova, N., Alison M. Dunning, Chenevix-Trench, G, Diether Lambrechts, Rachel T. Palmieri, Goodman, Marc T., Johnatty, Sharon E., Kelemen, Linda E., Hilda A. Pickett, Brooke L Fridley, Xiaoqing Chen, Surapon Wiangnon, Eilber Ursula, Nickels, S, Li, J., Goodman, M.T., Chen Xiaoqing, Johnatty,Sharon E., Pharoah, Paul D., Bogdanova, Natalia, Cook, L.S., Chaiwerawattana Arkom, Robert A. Vierkant, Linda E. Kelemen, Matsuno, R.K., Fridley, Brooke L., Chen, Xiaoqing, Lorna Rodriguez-Rodriguez, Muir, K., Evelyn Despierre, Lambrechts, Diether, Lophatananon Artitaya, Pickett, HA, Michael D Stutz, Lu Yi, Reddel, RR, Flesch-Janys, D., Bogdanova Natalia, Susan J Ramus, Gayther Simon A., Eilber, U., Sara H Olson, Shan Wang-Gohrke, Beesley Jonathan, Stefan Nickels, Massuger, LFAG, Nhu D. Le, Bandera, E.V., Gayther, S.A., Marc T. Goodman, Flesch-Janys, D, Eilber, U, Lu, Y, Michailidou Kyriaki, Pharoah, PD, Aben, Katja K.H., Gentry-Maharaj, A, Beesley, J, Stuart Macgregor, Chang-Claude Jenny, Vierkant, RA, Campbell Ian, Yi Lu, Lambertus A Kiemeney, MacGregor, S., Shahana Ahmed, Campbell, Ian, Hilda A Pickett, Lambrechts, Sandrina, Macgregor, S, Matsuno, Rayna K., Pharoah Paul D., Vergote, I., Linda E Kelemen, Easton, Douglas F., Brooks-Wilson, A., Reddel, R.R., Lambrechts Sandrina, Australian Ovarian Cancer Study Group, Reddel, Roger R., Ovarian Canc Assoc Consortium, Wang-Gohrke Shan, Olson, SH, Ovarian Cancer Association Consortium, Lambrechts, S., Chen, XQ, Aben, Katja K. H., HASH(0x55a67f6cc8d8), Dieter Flesch-Janys, Gentry-Maharaj Aleksandra, Muir Kenneth, Rider, DN, Ahmed Shahana, Ramus, SJ, Linda S Cook, Dork, T, Sharon E Johnatty, Chenevix-Trench Georgia, Nhu D Le, Menon, Usha, Dörk, Thilo, Gentry-Maharaj, A., Stutz, Michael D., Despierre, Evelyn, Ramus, Susan J., Alison M Dunning, Cook Linda S., Marees, T., Kelemen, LE, Dunning, Alison M., Runnebaum, Ingo B., Chen, X., Michailidou, K, Chen, X, Katja K. H. Aben, Johnatty Sharon E., Chang-Claude, J., Nickels Stefan, Easton, D.F., Chang-Claude, Jenny, Douglas F Easton, Roger R Reddel, Palmieri, R.T., Ahmed, Shahana, Goode Ellen L., Rider, David N., Lynne R Wilkens, Vierkant, Robert A., Chenevix-Trench, G., Aleksandra Gentry-Maharaj, Bandera, Elisa V., Macgregor Stuart, Ursula Eilber, Vrieling, A., Vergote Ignace, Pickett, H.A., Elisa V. Bandera, Rider David N., Galina Lurie, kConFab Investigators, Goode, EL, Orlow, I., Johnatty, SE, Kiemeney, LA, Gayther, SA +339 morecore +1 more sourceIncomplete pregnancy and risk of ovarian cancer: Results from two Australian case–control studies and systematic review [PDF]
, 2009 Although full-term pregnancies reduce the risk of ovarian cancer, it has not been conclusively established whether incomplete pregnancies also influence risk.Dick, Marie-Louise B., Purdie, David M., Dick, Marie Louise B, Green, Adele C., The Australian Ovarian Cancer Study Group, Siskind, Vic, Siskind, Victor, Australian Cancer Study Group (Ovarian Group), Vic Siskind, David M. Purdie, null null, Adèle C. Green, Marie-Louise B. Dick +12 morecore +1 more sourceAdvances in epithelial ovarian cancer
Australian Journal of General Practice, 2020 Most epithelial ovarian cancer occurs in older women, with a mean age at diagnosis of 62 years and an overall five‑year survival rate in Australia of 43%. Most women are diagnosed with advanced disease of high-grade serous type with 20-30% five-year survival; 70% relapse within three years of initial treatment.Deborah, Neesham, Anthony, Richards, Melissa, McGauran +2 moreopenaire +3 more sourcesAltered Expression Pattern of Topoisomerase IIα, in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy
Neoplasia: An International Journal for Oncology Research, 2006 OBJECTIVE: The aim of this study was to evaluate the expression of topoisomerase IIα (TOP2A) in epithelial and stromal cells of ovarian cancer. METHODS: TOP2A expression was analyzed in normal ovarian tissue and in laser-microdissected ovarian tumor ...Radoslav Chekerov, Irina Klaman, Menelaos Zafrakas, Dominique Könsgen, Alexander Mustea, Beate Petschke, Werner Lichtenegger, Jalid Sehouli, Edgar Dahl +8 moredoaj +1 more sourceDeciphering tumor immune microenvironment differences between high-grade serous and endometrioid ovarian cancer to investigate their potential in indicating immunotherapy response
Journal of Ovarian Research, 2023 Background Ovarian cancer is a significant public health concern with a poor prognosis for epithelial ovarian cancer. To explore the potential of immunotherapy in treating epithelial ovarian cancer, we investigated the immune microenvironments of 52 ...Hua Yang, Xiangyu Gu, Rong Fan, Qun Zhu, Sen Zhong, Xirun Wan, Qian Chen, Lan Zhu, Fengzhi Feng +8 moredoaj +1 more source